Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kathy Albain"'
Autor:
Aditya Bardia, Lajos Pusztai, Kathy Albain, Eva Maria Ciruelos, Seock-Ah Im, Dawn Hershman, Kevin Kalinsky, Claudine Isaacs, Delphine Loirat, Laura Testa, Eriko Tokunaga, Jiong Wu, Hannah Dry, William Barlow, Robert Kozarski, Micah Maxwell, Nadia Harbeck, Priyanka Sharma
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Despite advances in the treatment of early triple-negative breast cancer (TNBC), patients with residual invasive disease after neoadjuvant therapy have a high risk of disease recurrence and worse survival outcomes than those who have path
Externí odkaz:
https://doaj.org/article/3a1692a37ed9422f9c0bef0fb4017984
Autor:
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C. Wolff, Katherine Reeder-Hayes, Hope S. Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta Liu, Kathryn J. Ruddy, Yue Zheng, Shoshana M. Rosenberg, Richard D. Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann Partridge, Eric P. Winer, Ian Krop, Sara M. Tolaney
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract The excellent outcomes seen in patients treated with adjuvant trastuzumab emtansine (T-DM1) in the ATEMPT trial and the favorable toxicity profile associated with this agent make T-DM1 a potential therapeutic option for select patients with
Externí odkaz:
https://doaj.org/article/e88fcc1488804534afd42026e28dc869
Autor:
Mark Jesus M. Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Wen Li, Amy L. Delson, Smita Asare, Minetta C. Liu, Kathy Albain, A. Jo Chien, Andres Forero-Torres, Claudine Isaacs, Rita Nanda, Debu Tripathy, Angel Rodriguez, Himanshu Sethi, Alexey Aleshin, Matthew Rabinowitz, Jane Perlmutter, W. Fraser Symmans, Douglas Yee, Nola M. Hylton, Laura J. Esserman, Angela M. DeMichele, Hope S. Rugo, Laura J. van ’t Veer
Publikováno v:
Cancer Cell.
Autor:
Suzanne A. W. Fuqua, Sebastiano Ando, Ines Barone, Heidi Weiss, Lucio Miele, Kathy Albain, Ahcène Boumendjel, Attilio Di Pietro, Patrick Provost, Gabriela Dontu, Anna Tsimelzon, Kyle R. Covington, Matthew H. Herynk, Amanda Beyer, Michael T. Lewis, Guowei Gu, Jennifer Selever
PDF file - 69KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ddf8a537f6e73a338ef37b876eb3c9
https://doi.org/10.1158/1078-0432.22444580
https://doi.org/10.1158/1078-0432.22444580
Autor:
Suzanne A. W. Fuqua, Sebastiano Ando, Ines Barone, Heidi Weiss, Lucio Miele, Kathy Albain, Ahcène Boumendjel, Attilio Di Pietro, Patrick Provost, Gabriela Dontu, Anna Tsimelzon, Kyle R. Covington, Matthew H. Herynk, Amanda Beyer, Michael T. Lewis, Guowei Gu, Jennifer Selever
Purpose: Tamoxifen (Tam) is the most prescribed hormonal agent for treatment of estrogen receptor α (ERα)-positive breast cancer patients. Using microarray analysis, we observed that metastatic breast tumors resistant to Tam therapy had elevated le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9cb5c75a80a85b3a59255ba62b3f2f
https://doi.org/10.1158/1078-0432.c.6520232
https://doi.org/10.1158/1078-0432.c.6520232
Autor:
Suzanne A. W. Fuqua, Sebastiano Ando, Ines Barone, Heidi Weiss, Lucio Miele, Kathy Albain, Ahcène Boumendjel, Attilio Di Pietro, Patrick Provost, Gabriela Dontu, Anna Tsimelzon, Kyle R. Covington, Matthew H. Herynk, Amanda Beyer, Michael T. Lewis, Guowei Gu, Jennifer Selever
PDF file - 1575KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0773b0f7b5df71bc4012e1bc3340b10e
https://doi.org/10.1158/1078-0432.22444577
https://doi.org/10.1158/1078-0432.22444577
Autor:
Lucio Miele, Brian J. Nickoloff, Kathy Albain, Debra A. Tonetti, Jian-Zhong Qin, Urban Lendahl, Adriano Marchese, Deepali Bhandari, Amina Bashir, Suzanne Selvaggi, Kalliopi Siziopikou, Chindo Hicks, Prabha Rajan, Katharine Yao, Lu Hao, Giovanni Antico, Debra Wyatt, Joaquina Mascarenhas, Huiping Zhao, Jieun Yun, Clodia Osipo, Gwendolyn D'Souza, Haixi Miao, Paola Rizzo
Supplementary Figure 3 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b38250f587ea93e287b7dfeb2f7cae4
https://doi.org/10.1158/0008-5472.22374552
https://doi.org/10.1158/0008-5472.22374552
Autor:
Lucio Miele, Brian J. Nickoloff, Kathy Albain, Debra A. Tonetti, Jian-Zhong Qin, Urban Lendahl, Adriano Marchese, Deepali Bhandari, Amina Bashir, Suzanne Selvaggi, Kalliopi Siziopikou, Chindo Hicks, Prabha Rajan, Katharine Yao, Lu Hao, Giovanni Antico, Debra Wyatt, Joaquina Mascarenhas, Huiping Zhao, Jieun Yun, Clodia Osipo, Gwendolyn D'Souza, Haixi Miao, Paola Rizzo
Supplementary Methods and Materials, Figure Legends 1-7 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2713b6e46ada43f955b68f8820dfeb30
https://doi.org/10.1158/0008-5472.22374537
https://doi.org/10.1158/0008-5472.22374537
Autor:
Lucio Miele, Brian J. Nickoloff, Kathy Albain, Debra A. Tonetti, Jian-Zhong Qin, Urban Lendahl, Adriano Marchese, Deepali Bhandari, Amina Bashir, Suzanne Selvaggi, Kalliopi Siziopikou, Chindo Hicks, Prabha Rajan, Katharine Yao, Lu Hao, Giovanni Antico, Debra Wyatt, Joaquina Mascarenhas, Huiping Zhao, Jieun Yun, Clodia Osipo, Gwendolyn D'Souza, Haixi Miao, Paola Rizzo
Supplementary Figure 7 from Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded89a3d76252aba4a66343bb3620b3d
https://doi.org/10.1158/0008-5472.22374540.v1
https://doi.org/10.1158/0008-5472.22374540.v1
Autor:
Lucio Miele, Brian J. Nickoloff, Kathy Albain, Debra A. Tonetti, Jian-Zhong Qin, Urban Lendahl, Adriano Marchese, Deepali Bhandari, Amina Bashir, Suzanne Selvaggi, Kalliopi Siziopikou, Chindo Hicks, Prabha Rajan, Katharine Yao, Lu Hao, Giovanni Antico, Debra Wyatt, Joaquina Mascarenhas, Huiping Zhao, Jieun Yun, Clodia Osipo, Gwendolyn D'Souza, Haixi Miao, Paola Rizzo
High expression of Notch-1 and Jagged-1 mRNA correlates with poor prognosis in breast cancer. Elucidating the cross-talk between Notch and other major breast cancer pathways is necessary to determine which patients may benefit from Notch inhibitors,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0c6d141e719be26b590d974e1b9327c
https://doi.org/10.1158/0008-5472.c.6497490
https://doi.org/10.1158/0008-5472.c.6497490